NPPA REVISES CEILING PRICES OF OVER 900 DRUG FORMULATIONS

Why in the news?

NPPA revised prices of over 900 drug formulations with a marginal hike, part of a routine exercise in pharmaceutical pricing.

About the NPPA’s Revision of Drug Formulation Prices:

  • Marginal price increase observed in antibiotics and painkillers effective from Monday.
  • The National Pharmaceutical Pricing Authority (NPPA) permitted a slight price hike for specific medicines by 0.00551%.
  • The Department of Pharmaceuticals issues an annual list of revised ceiling prices for 923 scheduled drug formulations.
  • Additionally, retail prices of 65 formulations have been revised.
  • Price adjustment is part of the routine process.
  • In 2023, medicine prices witnessed a 12% increase.
  • In 2019, emergency measures were taken by NPPA, raising ceiling prices of 21 essential drugs by 50% due to discontinuation threats by several companies over high costs.
Source:scribd
What is NPPA (National Pharmaceutical Pricing Authority?

●   NPPA (National Pharmaceutical Pricing Authority) established in 1997 under the Department of Pharmaceuticals.

●   Mandated to regulate drug pricing and ensure accessibility of medicines at affordable rates.

●   Enforces Drugs (Prices Control) Order, monitors availability, handles legal matters, and collects data on pharmaceuticals.